These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36614268)

  • 1. Peptide Drug Conjugates and Their Role in Cancer Therapy.
    Heh E; Allen J; Ramirez F; Lovasz D; Fernandez L; Hogg T; Riva H; Holland N; Chacon J
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug conjugate-based anticancer therapy - Current status and perspectives.
    Yang Y; Wang S; Ma P; Jiang Y; Cheng K; Yu Y; Jiang N; Miao H; Tang Q; Liu F; Zha Y; Li N
    Cancer Lett; 2023 Jan; 552():215969. PubMed ID: 36279982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
    Zhang B; Wang M; Sun L; Liu J; Yin L; Xia M; Zhang L; Liu X; Cheng Y
    J Med Chem; 2024 Jul; 67(14):11469-11487. PubMed ID: 38980167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions.
    Li C; Shi K; Zhao S; Liu J; Zhai Q; Hou X; Xu J; Wang X; Liu J; Wu X; Fan W
    Pharmacol Res; 2024 Sep; 207():107341. PubMed ID: 39134188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent protein-drug conjugates - An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells.
    Porębska N; Ciura K; Chorążewska A; Zakrzewska M; Otlewski J; Opaliński Ł
    Biotechnol Adv; 2023 Oct; 67():108213. PubMed ID: 37453463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
    Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide cargo administration: current state and applications.
    Rohira H; Arora A; Kaur P; Chugh A
    Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.
    Alas M; Saghaeidehkordi A; Kaur K
    J Med Chem; 2021 Jan; 64(1):216-232. PubMed ID: 33382619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design of next generation antibody drug conjugates].
    Zhu GD; Fu YX
    Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-drug conjugates: Principles and opportunities.
    Phuna ZX; Kumar PA; Haroun E; Dutta D; Lim SH
    Life Sci; 2024 Jun; 347():122676. PubMed ID: 38688384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
    Lindberg J; Nilvebrant J; Nygren PÅ; Lehmann F
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic.
    Rizvi SFA; Zhang L; Zhang H; Fang Q
    ACS Pharmacol Transl Sci; 2024 Feb; 7(2):309-334. PubMed ID: 38357281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
    Paulus J; Sewald N
    J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of peptide-drug conjugates (PDCs) strategies for paclitaxel.
    Wang L; Chen H; Wang F; Zhang X
    Expert Opin Drug Deliv; 2022 Feb; 19(2):147-161. PubMed ID: 35130795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
    Wang M; Liu J; Xia M; Yin L; Zhang L; Liu X; Cheng Y
    Eur J Med Chem; 2024 Feb; 265():116119. PubMed ID: 38194773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions.
    Kumari S; Raj S; Babu MA; Bhatti GK; Bhatti JS
    Arch Pharm Res; 2024 Jan; 47(1):40-65. PubMed ID: 38153656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Source and exploration of the peptides used to construct peptide-drug conjugates.
    Zhou J; Li Y; Huang W; Shi W; Qian H
    Eur J Med Chem; 2021 Nov; 224():113712. PubMed ID: 34303870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.